Global Non-Opioid Pain Patch Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431701
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Acorda Therapeutics
  • Allergan
  • Endo Pharmaceuticals Inc.
  • GlaxoSmithKline plc.
  • Mylan N.V.
  • Pfizer, Inc.
  • MORE
Non-Opioid Pain Patch Market - Growth, Future Prospects and Competitive Analysis, 2017-2025, the global non-opioid pain patch market was valued at US$ 3.6 Bn in 2016, and is expected to reach US$ 5.0 Bn by 2025, expanding at a CAGR of 3.5% from 2017 to 2025.

Market Insights

Pain is reported as the major reason of public visit to any emergency department of any medical center. Various treatment options are available to deal with chronic and acute pain starting from medication, physical therapy to acupuncture, exercise or counselling technique. As per Institute of Medicine of The National Academies, more than 100 million Americans suffer from chronic pain which is much more compared to other health issues.

The non-opioid pain patch is a treatment for pain relief. The pain patch, when placed on painful area releases its medicine content through skin surface and block the pain signal transmission. The patches can be customized as per the applied area. To counteract the opioid abuse, newer, innovative and more effective non-opioid pain patches are being developed which in turn propel the non-opioid pain patch market growth.

Growing elderly population, increasing incidences of chronic and acute pain, rising opioid abuse and death from opioid overdose are the major drivers of the non-opioid pain patch market. Lower back-pain is the most common ailment followed by migraine or headache and neck pain. This rising prevalence of chronic pain is one of the major driver of non-opioid pain patch market. The increasing adoption of technologically advanced products, healthcare expenditure for R&D to develop innovative products boost up the growth of the non-opioid pain patch market. However, the lack of awareness in developing nations, demand of oral medication are few major challenges associated with the non-opioid pain patch market.

The non-opioid pain patch market is classified on the basis of patch type and the classification are of below types:
  • Lidocaine Patches
  • Diclofenac Patches
  • Capsaicin Patches
  • Methyl Salicylate Patches
  • Others
The non-opioid pain patch market is further segmented on the basis of distribution channels and the sub-segments are as follows:
  • Hospital pharmacy
  • Retail pharmacy/Independent pharmacy
  • E-commerce/ Online pharmacy
The hospital pharmacy hold the major market share, however retail pharmacy and online pharmacy are anticipated to face significant growth in forecasting periods.

Geographically, in the year 2016, North America is expected to have the major share of Non-opioid pain patch market followed by Europe. The growth of non-opioid pain patch market is majorly driven by the fact of opioid abuse. According to the study of Centers for Disease Control and Prevention (CDC), almost 91 people die every day from opioid overdose including prescribed opioid drugs. This fact in turn drive the non-opioid pain patch market. The healthcare expenditure for development of new products and patient health awareness attribute to the dominance of North American region. The huge number of population suffering from neurologic disorders, increasing geriatric population and developing healthcare infrastructure fuel the growth of the non-opioid pain patch market in Asia-Pacific region and it is expected to face significant growth in upcoming years due to the growing trend of health awareness.

Market Competition Assessment

The non-opioid pain patch market currently contains multiple companies having their products marketed. The manufacturers are developing new innovative products and the market is growing due to high adoption and accessibilities of these products. The companies include Teh Seng Pharmaceutical Mfg. Co., Ltd., Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd., Allergan, Pfizer Inc., Hisamitsu Pharmaceutical Co. Inc., GlaxoSmithKline plc., Mylan N.V., IBSA Institut Biochimque SA, Inc., Acorda Therapeutics and others.

Key Market Movements:
  • The rising prevalence of neurological disorder, chronic and acute pain, growing elderly population, increasing adoption of technologically advanced products, healthcare expenditure for R&D to manufacture newer and innovative products, increasing opioid abuse boost up the growth of non-opioid pain patch market.
  • The faster and effective outcome from oral medication, lack of product awareness are few of the challenges for the non-opioid pain patch market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acorda Therapeutics
  • Allergan
  • Endo Pharmaceuticals Inc.
  • GlaxoSmithKline plc.
  • Mylan N.V.
  • Pfizer, Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Non-Opioid Pain Patch Market Portraiture
2.2 Non-Opioid Pain Patch Market, by Patch Type, 2016 (US$ Mn)
2.3 Non-Opioid Pain Patch Market, by Distribution Channel Type, 2016 (US$ Mn)
2.4 Non-Opioid Pain Patch Market, by Geography, 2016 (Value %)

Chapter 3 Global Non-Opioid Pain Patch Market Analysis
3.1 Global Non-Opioid Pain Patch Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Non-Opioid Pain Patch Market, 2016 (Value %)

Chapter 4 Global Non-Opioid Pain Patch Market Analysis, By Patch
Type
4.1 Overview
4.1.1 Market Attractive Proposition of Non-Opioid Pain Patch Market, by Patch
Type, 2016
4.2 Lidocaine Patches
4.3 Diclofenac Patches
4.4 Capsaicin Patches
4.5 Methyl Salicylate Patches
4.6 Others

Chapter 5 Global Non-Opioid Pain Patch Market Analysis, By
Distribution Channel Type
5.1 Overview
5.1.1 Market Attractive Proposition of Non-Opioid Pain Patch Market, by
Distribution Channel Type, 2016
5.2 Hospital Pharmacy
5.3 Retail Pharmacy/Independent Pharmacy
5.4 E-commerce/ Online Pharmacy

Chapter 6 Global Non-Opioid Pain Patch Market Analysis, By
Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.2.2 North America Non-Opioid Pain Patch Market, by Distribution Channel
Type, 2015-2025 (US$ Mn)
6.2.3 North America Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.3.2 Europe Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015-2025 (US$ Mn)
6.3.3 Europe Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.4.2 Asia Pacific Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015-2025 (US$ Mn)
6.4.3 Asia - Pacific Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.5.2 Latin America Non-Opioid Pain Patch Market, by Distribution Channel
Type, 2015-2025 (US$ Mn)
6.5.3 Latin America Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
6.6 Middle East and Africa
6.6.1 Middle East and Africa Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.6.2 Middle East and Africa Non-Opioid Pain Patch Market, by Distribution
Channel Type, 2015-2025 (US$ Mn)
6.6.3 Middle East and Africa Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)

Chapter 7 Company Profiles
7.1 Teh Seng Pharmaceutical Mfg. Co., Ltd.
7.2 Endo Pharmaceuticals Inc.
7.3 Teikoku Seiyaku Co.
7.4 Allergan
7.5 Pfizer, Inc.
7.6 Hisamitsu Pharmaceutical Co. Inc.
7.7 GlaxoSmithKline plc.
7.8 Mylan N.V.
7.9 IBSA Institut Biochimque SA, Inc.
7.10 Acorda Therapeutics
7.11 Others

List of Figures
Fig. 1 Non-Opioid Pain Patch Treatment Market: Research Methodology
Fig. 2 Non-Opioid Pain Patch Market, by Patch Type, 2016 (US$ Mn)
Fig. 3 Non-Opioid Pain Patch Market, by Distribution Channel Type, 2016 (US$ Mn)
Fig. 4 Non-Opioid Pain Patch Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition
Fig. 6 Competitive Analysis: Global Non-Opioid Pain Patch Market, 2016 (Value %)

List of Tables
Table 1 Global Non-Opioid Pain Patch Market, By Patch Type (US$ Mn), 2015- 2025 (Value)
Table 2 Global Lidocaine Patches Market (US$ Mn), 2015-2025
Table 3 Global Diclofenac Patches Market (US$ Mn), 2015-2025
Table 4 Global Capsaicin Patches Market (US$ Mn), 2015-2025
Table 5 Global Methyl Salicylate Patches Market (US$ Mn), 2015-2025
Table 6 Global Others Market (US$ Mn), 2015-2025
Table 7 Global Non-Opioid Pain Patch Market, By Distribution Channel Type (US$ Mn), 2015-2025 (Value)
Table 8 Global Hospital Pharmacy Market (US$ Mn), 2015-2025
Table 9 Global Retail Pharmacy/Independent Pharmacy Market (US$ Mn), 2015-2025
Table 10 Global E-commerce/ Online Pharmacy Market (US$ Mn), 2015-2025
Table 11 Global Non-Opioid Pain Patch Market, by Geography, 2015 - 2025 (US$ Mn)
Table 12 North America Non-Opioid Pain Patch Market, by Patch Type, 2015 - 2025 (US$ Mn)
Table 13 North America Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015 - 2025 (US$ Mn)
Table 14 North America Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
Table 15 Europe Non-Opioid Pain Patch Market, by Patch Type, 2015 - 2025 (US$ Mn)
Table 16 Europe Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015 - 2025 (US$ Mn)
Table 17 Europe Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
Table 18 Asia Pacific Non-Opioid Pain Patch Market, by Patch Type, 2015 - 2025 (US$ Mn)
Table 19 Asia Pacific Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015 - 2025(US$ Mn)
Table 20 Asia - Pacific Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
Table 21 Latin America Non-Opioid Pain Patch Market, by Patch Type, 2015 - 2025 (US$ Mn)
Table 22 Latin America Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015 - 2025 (US$ Mn)
Table 23 Latin America Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
Table 24 Middle East and Africa Non-Opioid Pain Patch Market, by Patch Type, 2015 - 2025 (US$ Mn)
Table 25 Middle East and Africa Non-Opioid Pain Patch Market, by Distribution Channel Type,2015 - 2025 (US$ Mn)
Table 26 Middle East and Africa Non-Opioid Pain Patch Market, by Country, 2015 - 2025 (US$ Mn)
Table 27 Teh Seng Pharmaceutical Mfg. Co., Ltd.: Company Snapshot (Business Description;Financial Performance; Product Position/Portfolio; News Coverage)
Table 28 Endo Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 29 Teikoku Seiyaku Co.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 30 Allergan: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 31 Pfizer, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 32 Hisamitsu Pharmaceutical Co. Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 33 GlaxoSmithKline plc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 34 Mylan N.V.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 35 IBSA Institut Biochimque SA, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 36 Acorda Therapeutics: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 37 Others: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Teh Seng Pharmaceutical Mfg. Co., Ltd.
  • Endo Pharmaceuticals Inc.
  • Teikoku Seiyaku Co.
  • Allergan
  • Pfizer, Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • GlaxoSmithKline plc.
  • Mylan N.V.
  • IBSA Institut Biochimque SA, Inc.
  • Acorda Therapeutics
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll